en · de · es · fr · pt
cjc-1295-notes.peptides4962.com › Topic › Structure And Receptor Pharmacology — Reference Sheet

Structure And Receptor Pharmacology — Reference Sheet

By Editorial Desk · published 2025-11-14 · last reviewed 2026-01-01 · Topic

A practical reference on MOD GRF(1-29): what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2026-01-01 and is reviewed periodically as new material appears.

Structure And Receptor Pharmacology

Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.

Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.

Background and Molecular Features

The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.

CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.

Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.

Cjc-1295 at a glance

PropertyValueNotes
Peptide classSynthetic GHRH analogueBuilt on a 29 residue sequence
Primary targetGHRH receptor (GHRHR)Class B G protein coupled receptor
Unconjugated half lifeMinutesLimited by protease degradation
Key modificationFour residue substitutionsPositions 2, 8, 15 and 27
Common synonymModified GRF(1-29)Usually denotes the form without DAC

Background and Receptor Mechanism

Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.

At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.

Related pages on this site

Identity and Naming History

Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.

CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.

Supporting material

where P denotes the pressure of the system, V denotes the volume of the gas, k is a constant value representative of the temperature of the system and amount of gas. So long as temperature remains constant the same amount of energy given to the system persists throughout its operation and therefore, theoretically, the value of k will remain constant. However, due to the derivation of pressure as perpendicular applied force and the probabilistic likelihood of collisions with other particles through collision theory, the application of force to a surface may not be infinitely constant for such values of V, but will have a limit when differentiating such values over a given time. Forcing the volume V of the fixed quantity of gas to increase, keeping the gas at the initially measured temperature, the pressure P must decrease proportionally. Conversely, reducing the volume of the gas increases the pressure. Boyle's law is used to predict the result of introducing a change, in volume and pressure only, to the initial state of a fixed quantity of gas. The initial and final volumes and pressures of the fixed amount of gas, where the initial and final temperatures are the same (heating or cooling will be required to meet this condition), are related by the equation:

== Dissolution == On 25 October 2021, in the 2021 Sudan coup d'état, Chairman Abdel Fattah al-Burhan dissolved the Council and removed Prime Minister Abdalla Hamdok from office. He re-formed the TSC with new membership on November 11, 2021. On November 21, 2021, al-Burhan signed a deal with Hamdok that reinstated him as prime minister, provided for the release of all political prisoners detained in the coup, and restored the 2019 Draft Constitutional Declaration.

=== Keratoconjunctivitis sicca (dry eye disease) === Keratoconjunctivitis sicca, commonly known as dry eye, is a prevalent condition of the tear film. Despite the eyes being dry, those affected can still experience watering of the eyes, which is, in fact, a response to irritation caused by the original tear film deficiency. Lack of Meibomian gland secretion can mean that the tears are not enveloped in a hydrophobic film coat, leading to tears spilling onto the face. Treatment for dry eyes to compensate for the loss of tear film include eye-drops composed of methyl cellulose or carboxy- methyl cellulose or hemi-cellulose in strengths of either 0.5% or 1% depending upon the severity of drying up of the cornea. For meibomian gland dysfunction (MGD), one of the treatments is intense pulsed light (IPL). It is a therapeutic modality that was originally developed for dermatological applications and later adopted in ophthalmology.

Receiving a red card (red card suspensions could be extended for serious offenses). Receiving two yellow cards in the tournament. This yellow card count was reset after the completion of the group stage and again after the quarterfinals. Resets did not apply to suspensions; a player whose yellow card count reached two in the match immediately before a reset was still suspended for the next match. During qualification for the World Cup, Cristiano Ronaldo was sent off for violent conduct in Portugal's penultimate match against the Republic of Ireland, with such an offense typically resulting in a ban of at least two matches. Ronaldo was handed a three-match ban, though the final two matches of the ban were suspended for a one-year probationary period, making him eligible to appear in Portugal's opening World Cup match. On May 8, 2026, the Bureau of the FIFA Council amended the tournament regulations so that pending one- or two-match suspensions resulting from red cards for two yellow cards, denying an obvious goal-scoring opportunity, or serious foul play during qualification would no longer be carried forward to the final competition. This exempted Argentina's Nicolás Otamendi, Ecuador's Moisés Caicedo, and Qatar's Tarek Salman from serving their qualifying-round suspensions during the tournament, with the bans to instead be served in a subsequent competition. During the round of 32, United States player Folarin Balogun was sent off, and was expected to be banned for the forthcoming round of 16 game against Belgium. Following lobbying from U.S.

=== General === Peter Atkins & Julio de Paula, 2006, "Physical chemistry," 8th Edn., New York, NY, USA:Macmillan, ISBN 0716787598, accessed 21 June 2015. [E.g., see p. 422 for a group theoretical/symmetry description of atomic orbitals contributing to bonding in methane, CH4, and pp. 390f for estimation of π-electron binding energy for 1,3-butadiene by the Hückel method.] Thomas H. Lowry & Kathleen Schueller Richardson, 1987, Mechanism and Theory in Organic Chemistry, 3rd Edn., New York, NY, USA:Harper & Row, ISBN 0060440848, accessed 20 June 2015. [The authoritative textbook on the subject, containing a number of appendices that provide technical details on molecular orbital theory, kinetic isotope effects, transition state theory, and radical chemistry.] Eric V. Anslyn & Dennis A. Dougherty, 2006, Modern Physical Organic Chemistry, Sausalito, Calif.: University Science Books, ISBN 1891389319. [A modernized and streamlined treatment with an emphasis on applications and cross-disciplinary connections.] Michael B. Smith & Jerry March, 2007, "March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure," 6th Ed., New York, NY, USA:Wiley & Sons, ISBN 0470084944, accessed 19 June 2015. Francis A. Carey & Richard J. Sundberg, 2006, "Advanced Organic Chemistry: Part A: Structure and Mechanisms," 4th Edn., New York, NY, USA:Springer Science & Business Media, ISBN 0306468565, accessed 19 June 2015. Hammett, Louis P. (1940) Physical Organic Chemistry, New York, NY, USA: McGraw Hill, accessed 20 June 2015.

Sources: en.wikipedia.org

Supporting material

Penbutolol (brand names Levatol, Levatolol, Lobeta, Paginol, Hostabloc, Betapressin) is a medication in the class of beta blockers, used in the treatment of high blood pressure. Penbutolol is able to bind to both beta-1 adrenergic receptors and beta-2 adrenergic receptors (the two subtypes), thus making it a non-selective β blocker. Penbutolol is a sympathomimetic drug with properties allowing it to act as a partial agonist at β adrenergic receptors. It was approved by the FDA in 1987 and was withdrawn from the US market by January 2015.

=== September === 1 September The James Webb Space Telescope takes its first direct images of a planet beyond the Solar System. The exoplanet, HIP 65426 b, is revealed in different bands of infrared light. Neuroscientists report the discovery of the axo-ciliary synapse – communication between serotonergic axons and antenna-like primary cilia of CA1 pyramidal neurons that alters the neuron's epigenetic state in the nucleus. Scientists elaborate a need for an evidence-based reform of regulation of genetically modified crops (moving from regulation based on characteristics of the development-process to characteristics of the product) in a paywalled article. 2 September – A first spatiotemporal map reveals key insights about axolotl brain regeneration. 5 September – Researchers report the development of remote controlled cyborg cockroaches functional if moving to sunlight for recharging. 6 September – The U.S. Department of Agriculture approves a new purple tomato, genetically modified to alter its colour and enhance its nutritional quality. 7 September – A new malaria vaccine developed by the University of Oxford is shown to be ~80% effective at preventing the disease. 8 September – A study adds to the accumulating research indicating postexposure antiviral TIPs could be an effective countermeasure that reduces COVID-19 transmission. In September, India and China approve the two first nasal COVID-19 vaccines which may (as boosters) also reduce transmission (sterilizing immunity).

Provides straightforward information about effects arising from individual compounds in complex or natural samples separated in parallel. Combines chromatographic separation with effect-directed detection using enzymatic or biological assays. Helps to select important compounds from a sample for further characterization using high-resolution mass spectrometry. Offers unique benefits such as super-hyphenation, minimum sample preparation requirements, detection of multi-modulating compounds, and distinguishing agonistic versus antagonistic effects.

where S1 is a polypeptide, P1 and P2 are products. The first chemical step (3) includes the formation of a covalent acyl-enzyme intermediate. The second step (4) is the deacylation step. The group H+, initially found on the enzyme, but not in water, appears in the product before the step of hydrolysis, therefore it may be considered as an additional group of the enzymatic reaction. Thus, the reaction (3) shows that the enzyme acts as a powerful reactant of the reaction. According to the proposed concept, the H transport from the enzyme promotes the first reactant conversion, breakdown of the first initial chemical bond (between groups P1 and P2). The step of hydrolysis leads to a breakdown of the second chemical bond and regeneration of the enzyme. The proposed chemical mechanism does not depend on the concentration of the substrates or products in the medium. However, a shift in their concentration mainly causes free energy changes in the first and final steps of the reactions (1) and (2) due to the changes in the free energy content of every molecule, whether S or P, in water solution. This approach is in accordance with the following mechanism of muscle contraction. The final step of ATP hydrolysis in skeletal muscle is the product release caused by the association of myosin heads with actin. The closing of the actin-binding cleft during the association reaction is structurally coupled with the opening of the nucleotide-binding pocket on the myosin active site. Notably, the final steps of ATP hydrolysis include the fast release of phosphate and the slow release of ADP.

Sources: en.wikipedia.org

Notes from published material

== Complications == The denaturing of proteins by an aqueous solution containing many types of ions is more complicated as all the ions can act, according to their Hofmeister activity, i.e., a fractional number specifying the position of the ion in the series (given previously) in terms of its relative efficiency in denaturing a reference protein. At high salt concentrations lysozyme protein aggregation obeys the Hofmeister series originally observed by Hofmeister in the 1870s, but at low salt concentrations electrostatic interactions rather than ion dispersion forces affect protein stability resulting in the series being reversed. However, at high concentrations of salt, the solubility of the proteins drops sharply and proteins can precipitate out. Ion binding to carboxylic surface groups of macromolecules can either follow the Hofmeister series or the reversed Hofmeister series depending on the pH. The concept of Hofmeister ionicity Ih has been invoked by Dharma-wardana et al. where it is proposed to define Ih as a sum over all ionic species, of the product of the ionic concentration (mole fraction) and a fractional number specifying the "Hofmeister strength" of the ion in denaturing a given reference protein. The concept of ionicity (as a measure of the Hofmeister strength) used here has to be distinguished from ionic strength as used in electrochemistry, and also from its use in the theory of solid semiconductors.

== Advantages == A major advantage of the SELDI process is the chromatographic separation step. While liquid chromatography-mass spectrometry (LC-MS) is based on the elution of analytes in the separated sample, separation in SELDI is based on retention. Any sample components that interfere with analytical measurements, such as salts, detergents, and buffers, are washed away before analysis with mass spectrometry. Only the analytes that are bound to the surface are analyzed, reducing the overall complexity of the sample. As a result, there is an increased probability of detecting analytes that are present in lower concentrations. Because of the initial separation step, protein profiles can be obtained from samples of as few as 25-50 cells. In biological applications, SELDI-TOF-MS has a major advantage in that the technique does not require the use of radioactive isotopes. Furthermore, an assay can be sampled at multiple time points during an experiment. Additionally, in proteomics, the biomarker discovery, identification, and validation steps can all be done on the SELDI surface.

In March 2017, infighting within the CJNG showed when Oseguera ordered the murder of high-ranking CJNG member Carlos Enrique Sánchez, alias "El Cholo". The plot to murder Sánchez, who was targeted by Oseguera after murdering a CJNG financial operator nicknamed "El Colombiano", failed. Sánchez and CJNG co-founder Érick Valencia Salazar, alias "El 85", departed from the CJNG and formed a new cartel called Nueva Plaza Cartel. Upon its formation, Sánchez was made leader of the newly formed cartel. According to InSight Crime, the Nueva Plaza Cartel retaliated against the failed murder of Sánchez by murdering the person in charge of the CJNG's hit squad, nicknamed "El Kartón" or "El Marro", in August 2017. CJNG co-founder Emilio Alejandro Pulido Salazar, alias "El Tiburón", would defect to the Nueva Plaza Cartel as well. Valencia and Sánchez also began a war with their former cartel as well. In 2019, Valencia and Sánchez were still reported to leaders of the breakaway Nueva Plaza Cartel. They also were still waging war against the CJNG and had even formed an alliance with the Sinaloa Cartel. By 2019, Jorge Luis Mendoza Cárdenas, alias "La Garra", was listed by the U.S. Drug Enforcement Administration (DEA) as being in charge of the CJNG's trafficking operations to the United States and serves as the CJNG's liaison as well. In January 2020, senior CJNG hitwoman María Guadalupe López Esquive, alias "La Catrina" died following a shootout with police. López, also known as "Dame of Death", was suspected of being the CJNG leader in Mexico's Tierra Caliente region.

== External links == "Dr. A. Ajayaghosh". Awardee profile. Infosys Science Foundation. 2016. "Dr. A. Ajayaghosh". Infosys Science Foundation. 26 September 2013. p. YouTube video. "Dr. A. Ajayaghosh'' https://scholar.google.com/citations?user=bYdujAwAAAAJ&hl=en

Skin turgor (associated alongside capillary refilling) refers to the natural ability of the skin to instantly snap back into place after being stretched or deformed. When a person becomes dehydrated, their skin loses baseline elasticity, causing a noticeable drop in turgor that serves as a primary clinical marker for fluid loss. To assess this, a healthcare provider gently pinches the skin on areas like the forearm or the back of the hand and measures how many seconds it takes to flatten out completely. Poor turgor causes the pinches tissue to remain elevated in a state known as "tenting," or in cases of server fluid depletion, it can produce a shriveled appearance historically termed the "washerwoman's hand" symptom.

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 the same as modified GRF(1-29)?

The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.

What does the acronym DAC refer to?

DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.

Does this peptide occur naturally in the body?

No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.

What is the difference between CJC-1295 and natural GHRH?

Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.

Network